Biotech News

Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel

Vivos Therapeutics (VVOS)Vivos TherapeuticsFinancing

Transaction Expected to Add More Than $10 Million to Stockholders' Equity as Vivos Forms Strategic Alliances Offering Potential New Revenue and Profit Opportunities Transaction Expected to Add More Than $10 Million to Stockholders' Equity as Vivos Forms Strategic Alliances Offering Potential New Revenue and Profit Opportunities

Related news

Vivos Therapeutics

Sleep-Related Breathing Disorder Platform Vivos Therapeutics is a medical technology and healthcare services company focused on obstructive sleep apnea and related breathing disorders. Its approach combines proprietary oral appliances with diagnostic and clinical services intended to address the anatomical contributors to impaired...

Recent company news

Stock data

Close
0.06 USD
Market cap
9.42M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States